YFYYouth for Youth
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
In 2016, sales of 3-ply paper only amounted to NT$870 million, while in 2017 sales of the product exceeded NT$1 billion, nearly a 19 percent increase and its share of the toilet paper market rose to 16 percent, according to YFY.
Among them YFY, Taiwan's largest paper & pulp manufacturer, obtained a loan of NT$10.5 billion (US$350 million) from a syndicate of 12 Taiwanese banks for lending rate of about 1.6%-1.65% per annum.
YFY has been developing the RFID business for nearly 10 years, with three subsidiaries Arizon, Yeon Technologies Co., Ltd., and Yuen Foong Precision Electronics Co., Ltd.
YFY's bio-pulp plant in Yangzhou (Jiangsu Province, China), which saves 30% in cost compared to making pulp with wastepaper, has gradually improved capacity utilization and is expected to boost profits from supplying industrial paper in China.
YFY Inc., one of the largest tissue paper suppliers in Taiwan, said prices of pulp which accounts for a majority of production costs, have risen by more than 50 percent since mid-2017, and keep rising.
(YFY) saw its No.5 and No.6 household paper-making machines and bio-pulp plant in Yangzhou (Jiangsu Province, China) come online in the third quarter, with 50% of capacity utilization currently and expected to gradually grow due to increasing orders.
and paper producer YFY among others, according to the report, which emphasized Chinese and foreign companies were also affected.
(YFY) and NT$2.5 billion (US$83.33 million) to Tonyi Industrial Corp.
(YFY) may suffer impact from price decline of the product.
Insiders attribute BOT's lead to its involvement in several big loans, including NT$35 billion (US$1.17 billion) extended to Dragon Steel and NT$25 billion (US$833.33 million) to Radium Life Technology in addition to the ones offered to conglomerates as Uni-President Group, Formosa Plastics Group, and YFY Group.
(YFY), Ltd., are selected by DOH (Department of Health Taiwan) to be the first companies to apply for new-drug certification simultaneously in Taiwan and China under the ECFA (Economic Cooperation Framework Agreement).